Sage Journals: Discover world-class research

Retricted access

Research article

First published 2023-3

Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer

Donghui Hou, Xiaomin Zheng, Wei Song [...]

Acta Radiologica

Retricted access

Case report

First published 2019-10

Response to alectinib oil-based suspension in anaplastic lymphoma kinase-positive non-small cell lung cancer in a patient unable to swallow: A case report

Maria Teresa Bejarano Varas, Scott Gould, Marjory Charlot

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2019-08

The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer

Yuan He, Rui Gong, Li-Yue Sun [...]

Genetic Testing and Molecular Biomarkers

Retricted access

Research article

First published 2022-4

Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases

Jacopo Giuliani

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2019

Cost-effectiveness analysis of alectinib versus crizotinib in first-line treatment of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer

Ravasio R, Tiseo M, Pradelli L [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2023-9

Economic burden in patients with anaplastic lymphoma kinase ( ALK )-positive non-small cell lung cancer (NSCLC),with or without brain metastases,receiving first-line ALK inhibitors

Yanyu Wu, Kaili Ren, Yin Wan [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2018-11

Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients

Giulio Metro, Diana Giannarelli, Angelo Sidoni [...]

The International Journal of Biological Markers

Open access

Review article

First published 2017-12

Ceritinib: A primer for pharmacists

Trang H Au, Courtney C Cavalieri, David D Stenehjem

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-1

Avascular necrosis during alectinib treatment: Case report

Pınar Gürsoy

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-7

Alectinib-induced hemolytic anemia

Chung-Shien Lee, Kevin Sullivan

Journal of Oncology Pharmacy Practice

Search results